Salford Lung Study in chronic obstructive pulmonary disease (SLS COPD): follow-up interviews on patient-centred outcomes

Salford Lung Study in chronic obstructive pulmonary disease (SLS COPD): follow-up interviews on patient-centred outcomesSalford Lung Study in chronic obstructive pulmonary disease (SLS COPD): follow-up interviews on patient-centred outcomes, Published online: 15 December 2017; doi:10.1038/s41533-017-0066-2Interviews with patients undergoing a clinical trial for chronic lung disease highlights the impact of breathlessness on quality of life. Henrik Svedsater at GlaxoSmithKline in the UK, and co-workers, wanted to dig deeper into patient perceptions of COPD during the Salford Lung Study in Chronic Obstructive Pulmonary Disease (SLS COPD) clinical trial, which trialed an alternative self-administered inhaler treatment. To this end, Svedsater’s team administered questionnaires and interviewed 400 patients involved in SLS COPD, to examine disease impacts on their quality of life. The patients cited breathlessness as having the greatest bearing on daily life, particularly on their ability to carry out physical tasks and continue a self-care regime. Investigations of disease impact should be incorporated into future clinical trials, particularly to assess how improving lung function affects patient perceptions and quality of life.

Source: npj Primary Care Respiratory Medicine - December 15, 2017 Category: Primary Care Authors: Lynda Doward Henrik Svedsater Diane Whalley Rebecca Crawford David Leather James Lay-Flurrie Nick Bosanquet Source Type: research